Cargando…
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
The authors performed this study to investigate the efficacy and safety of a rosuvastatin (RSV)/amlodipine (AML) polypill compared with those of atorvastatin (ATV)/AML polypill. We included 259 patients from 21 institutions in Korea. Patients were randomly assigned to 1 of 3 treatment groups: RSV 10...
Autores principales: | Jung, Hae Won, Kim, Chang‐Yeon, Hong, Seung‐Pyo, Bae, Han‐Joon, Choi, Ji Yong, Ryu, Jae Kean, Lee, Jin‐bae, Lee, Kyoung‐Hoon, Han, Kyoo‐Rok, Yang, Dong‐Heon, Park, Chang‐Gyu, Yu, Gheol‐Woong, Rhee, Moo‐Yong, Park, Sung‐Ji, Hyon, Min‐Su, Shin, Joon‐Han, Hong, Bum‐Kee, Jin, Han‐Young, Lee, Sung‐Yun, Seol, Sang‐Hoon, Lee, Sang‐Rok, Kim, Song‐Yi, Lee, Kwang‐Je, Cho, Eun‐Joo, Nam, Chang‐Wook, Park, Tae‐Ho, Kim, Ung, Kim, Kee‐Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497028/ https://www.ncbi.nlm.nih.gov/pubmed/37584254 http://dx.doi.org/10.1111/jch.14715 |
Ejemplares similares
-
S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018) -
Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020) -
Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
por: Yoon, Deok Yong, et al.
Publicado: (2020) -
Application of an LC–MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study
por: Shah, Jaivik V., et al.
Publicado: (2017) -
Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)